BIOXODES
ActiveSummary
The computed 12-month bankruptcy probability of BIOXODES is 1.6% (moderate). The 2025 annual accounts show negative equity (-€1.7m) and a net result of -€3.4m. Equity is shrinking by ~11.1% per year across the filed fiscal years. Its solvency ranks better than 9% of 239 sector peers (NACE 72, fiscal year 2025). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
07-08
State Gazette act
Reappointments: SRL XMF, SRL PHMBIO+ and 3 othersPermanent representatives: Marc DECHAMPS, Philippe MONTEYNE and 4 others · Appointment: SRL PwC Réviseurs d'Enreprises (statutory auditor)17 facts ▸
- General meeting, 30-06-2026
- Director reappointment, SRL XMF (director)
- Permanent representative, Marc DECHAMPS (permanent representative)
- Director reappointment, SRL PHMBIO+ (director)
- Permanent representative, Philippe MONTEYNE (permanent representative)
- Director reappointment, SC CAPITAL & CROISSANCE (director)
- Permanent representative, Pierre DETRIXHE (permanent representative)
- Director reappointment, SA S.F.P.I. (Société Fédérale de Participations et d'Investissements) (director)
- Permanent representative, François FONTAINE (permanent representative)
- Director reappointment, SAS CROUGHS R&D CONSULTING (director)
- Permanent representative, Thérèse CROUGHS (permanent representative)
- Board meeting, 03-07-2026
- +5 further facts in this act
About the unread acts
Of the 32 Belgian State Gazette acts we know for this company, 1 has been read. The other 31 have not been read yet: what they contain is neither established nor disproved here.